Differential sensitivity of breast cancer cells to tumor necrosis factor-α:: Involvement of protein kinase C

被引:43
作者
Basu, A
Mohanty, S
Sun, B
机构
[1] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA
[2] Univ N Texas, Hlth Sci Ctr, Inst Canc Res, Ft Worth, TX 76107 USA
关键词
tumor necrosis factor-alpha; protein kinase C; caspases; apoptosis; NF-kappa B; breast cancer cells; PKC epsilon;
D O I
10.1006/bbrc.2000.4209
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have compared several breast cancer cell lines that differ in their responsiveness to TNF to determine the involvement of PKC isozymes in regulating sensitivity of breast cancer cells to TNF. While MCF-7 and BT-20 cells were responsive to TNF without any metabolic inhibitors, CAMA-1 and SKBR-3 cells responded to TNF in the presence of cycloheximide; MDA-MB-231 and Hs578t cells were resistant to TNF even in the presence of cycloheximide. Bisindolylmaleimide (BIM), an inhibitor of PKC, either alone (MCF-7 and BT-20) or in combination with cycloheximide enhanced sensitivity of these cells to TNF. The PKC isozyme profile of MCF-7 cells was similar to BT-20 cells and that of CAMA-1 cells was similar to SKBR-3 cells. MCF-7, BT-20 and MDA-MB-231 cells that were most responsive to BIM-mediated sensitization to TNF contained relatively high level of PKC epsilon and proteolytic cleavage of PKC epsilon correlated with TNF-induced cell death. BIM did not inhibit NF-kappaB activation by TNF but caused activation of caspases and enhanced cleavage of PKC delta and -epsilon. These results suggest that proteolytic cleavage of PKC epsilon may be associated with PKC inhibitor mediated sensitization of breast cancer cells to TNF. (C) 2001 Academic Press.
引用
收藏
页码:883 / 891
页数:9
相关论文
共 29 条
[1]   Overexpression of protein kinase C-η attenuates caspase activation and tumor necrosis factor-α-induced cell death [J].
Akkaraju, GR ;
Basu, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 279 (01) :103-107
[2]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[3]   THE POTENTIAL OF PROTEIN-KINASE-C AS A TARGET FOR ANTICANCER TREATMENT [J].
BASU, A .
PHARMACOLOGY & THERAPEUTICS, 1993, 59 (03) :257-280
[4]  
Basu A, 1996, CELL GROWTH DIFFER, V7, P1507
[5]  
BASU A, 1990, J BIOL CHEM, V265, P8451
[6]   The involvement of novel protein kinase C isozymes in influencing sensitivity of breast cancer MCF-7 cells to tumor necrosis factor-α [J].
Basu, A .
MOLECULAR PHARMACOLOGY, 1998, 53 (01) :105-111
[7]   An essential role for NF-kappa B in preventing TNF-alpha-induced cell death [J].
Beg, AA ;
Baltimore, D .
SCIENCE, 1996, 274 (5288) :782-784
[8]   MOLECULAR MECHANISMS OF TUMOR NECROSIS FACTOR-INDUCED CYTOTOXICITY - WHAT WE DO UNDERSTAND AND WHAT WE DO NOT [J].
BEYAERT, R ;
FIERS, W .
FEBS LETTERS, 1994, 340 (1-2) :9-16
[9]   Caspases: the executioners of apoptosis [J].
Cohen, GM .
BIOCHEMICAL JOURNAL, 1997, 326 :1-16
[10]   A HIGH-MOLECULAR-WEIGHT COMPONENT OF THE HUMAN-TUMOR NECROSIS FACTOR RECEPTOR IS ASSOCIATED WITH CYTOTOXICITY [J].
CREASEY, AA ;
YAMAMOTO, R ;
VITT, CR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (10) :3293-3297